MindWalk Holdings Corp. (HYFT)
| Market Cap | 65.31M -46.6% |
| Revenue (ttm) | 11.43M +46.4% |
| Net Income | -10.25M |
| EPS | -0.22 |
| Shares Out | 46.99M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 73,601 |
| Open | 1.440 |
| Previous Close | 1.420 |
| Day's Range | 1.380 - 1.440 |
| 52-Week Range | 0.990 - 2.990 |
| Beta | 0.82 |
| Analysts | Strong Buy |
| Price Target | 4.33 (+211.51%) |
| Earnings Date | Sep 14, 2026 |
About HYFT
MindWalk Holdings Corp. operates as a bio-native AI company. The company discovers and develops biologics through HYFT Technology and LensAI platform, as well as develops AI drug discovery and biologics through ReefIQ technology. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.
Financial Performance
In fiscal year 2026, MindWalk Holdings's revenue was 15.56 million, an increase of 46.41% compared to the previous year's 10.63 million. Losses were -13.95 million, -53.86% less than in 2025.
Financial numbers in CAD Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for HYFT stock is "Strong Buy." The 12-month stock price target is $4.33, which is an increase of 211.51% from the latest price.
News
MindWalk Holdings Registration statement: Registration filing
MindWalk Holdings filed a registration statement on July 28, 2026, providing details about a securities offering with the SEC.
MindWalk showcases ReefIQ for AI drug discovery
MindWalk (HYFT) Holdings “unveiled the first public demonstration of ReefIQ, its biological context layer for AI drug discovery, running on AMD Instinct(TM) at AMD’s Advancing AI 2026 in San Francisco...
MindWalk Showcases ReefIQ™ for AI Drug Discovery at AMD Advancing AI
AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. (“MindWalk”) (NASDAQ: HYFT), a Bio-Native AI company, today unveiled the first public demonstration of ReefIQ™, its biological con...
MindWalk Holdings Earnings Call Transcript: Q4 2026
Revenue grew 46% year-over-year with gross margin expanding to 59%, while net loss narrowed by more than half. First recurring SaaS revenue was booked, and strategic divestitures strengthened the balance sheet. Market focus is shifting to proprietary data and context, validating the platform's unique position.
MindWalk Holdings Earnings release: Q4 2026
MindWalk Holdings released its Q4 2026 earnings on July 22, 2026, summarizing the period's financial results.
MindWalk Holdings Annual report: Q4 2026
MindWalk Holdings has published its Q4 2026 annual report on July 22, 2026.
MindWalk Holdings Slides: Q4 2026
MindWalk Holdings has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on July 22, 2026.
MindWalk Holdings Corp. Reports Fiscal 2026 Results: Revenue Up 46% as the Company Completes Its Pivot to Bio-Native AI Infrastructure
AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today reported financial results for the fiscal year ended April 30, 2026. A...
MindWalk files $250M mixed securities shelf
16:06 EDT MindWalk (HYFT) files $250M mixed securities shelf
MindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for Fourth Quarter and Full Fiscal Year 2026 on July 22, 2026
AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. (“MindWalk” or the “Company”) (NASDAQ: HYFT), a Bio-Native AI company, today announced that it will report financial results for t...
MindWalk Holdings Registration statement: Registration filing
MindWalk Holdings filed a registration statement on July 13, 2026, providing details about a securities offering with the SEC.
MindWalk added to Russell 3000E Index
MindWalk (HYFT) Holdings has been added to the Russell 3000E Index, effective after the U.S. market close on June 26, as part of the FTSE Russell June 2026 semi-annual Russell…
MindWalk Holdings Corp. (NASDAQ: HYFT) Added to the Russell 3000E Index, Expanding Institutional Investment Opportunity
AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. (“MindWalk”) (NASDAQ: HYFT), a Bio-Native AI company, today announced that it has been added to the Russell 3000E Index, effective...
MindWalk files European patent application for high-dimensional data structures
MindWalk (HYFT) Holdings announced the filing of European patent application No. EP26187897.9, directed to high-dimensional data structures for biological subsequences and property inference. The appl...
MindWalk (NASDAQ: HYFT) Files Patent for High-Dimensional Biological Data Architecture Powering AI Drug Discovery
AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. (“MindWalk”) (NASDAQ: HYFT), a Bio-Native AI company, today announced the filing of European patent application No. EP26187897.9, ...
MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery
AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. (“MindWalk”) (NASDAQ: HYFT), a bio-native AI company, today announced that President and Chief Executive Officer Dr. Jennifer Bath...
MindWalk launches ReefIQ context layer
MindWalk (HYFT) Holdings launched ReefIQ, a HYFT-powered biological context layer for AI drug discovery and biologics development, that sits between client discovery data and AI reasoning workflows. B...
MindWalk Holdings Corp. (NASDAQ: HYFT) Launches ReefIQ™, a Biological Context Layer for AI Drug Discovery
VICTORIA, British Columbia--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. (“MindWalk”) (NASDAQ: HYFT), a bio-native AI company, today launched ReefIQ™, a HYFT-powered biological context layer...
MindWalk says preclinical dengue data support HYFT computational prediction
MindWalk (HYFT) Holdings reported preclinical dengue data that support a computational prediction its HYFT platform generated before any animal was immunized. HYFT computationally identified a candida...
MindWalk's Preclinical Dengue Data Support a HYFT® Computational Prediction: Immunogens Designed on the Predicted Target Elicited Cross-Reactive Antibodies Against Antigens of All Four Dengue Serotypes, Reproduced Across Two Independent Campaigns
AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. (Nasdaq: HYFT) today reported preclinical dengue data that support a computational prediction its HYFT® platform generated before ...
MindWalk announces launch of Pandemic Response Platform
MindWalk (HYFT) Holdings announced the launch of its Pandemic Response Platform, a deployment configuration of the Company’s proprietary HYFT biological pattern system and LensAI platform purpose-buil...
MindWalk Holdings Deploys Pandemic Response Platform via HYFT® Technology as Ebola and Hantavirus Outbreaks Expose the Limits of Strain-Specific Coverage
AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. (NASDAQ: HYFT), a bio-native AI therapeutic research and technology company, today announced the launch of its Pandemic Response P...
MindWalk identifies over 20 partner-owned drug programs reaching clinical trials
MindWalk (HYFT) Holdings released a systematic report identifying over 20 discovery-originated drug candidates with documented origins in antibody discovery work performed at MindWalk facilities. Ten ...
The Biology Came First.
AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. (NASDAQ: HYFT) today released a systematic report identifying over 20 discovery-originated drug candidates with documented origins...
MindWalk initiated with a Buy at JonesResearch
JonesResearch initiated coverage of MindWalk (HYFT) with a Buy rating and $5 price target MindWalk offers an end-to-end ecosystem for drug discovery, but “what sets it apart” is its Bio-Native…